| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/22/2002 | WO2002040008A3 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 08/22/2002 | WO2002032377A3 Estrogen receptor modulators |
| 08/22/2002 | WO2002024221A3 Notch receptor agonists and uses |
| 08/22/2002 | WO2002000001A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF |
| 08/22/2002 | WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115853 6-(3-nitrophenyl)-3H-benzooxazol-2-one for example; contraceptives, treating hormone dependent tumors, endometriosis; progesterone receptor agonists and antagonists |
| 08/22/2002 | US20020115727 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines |
| 08/22/2002 | US20020115726 Methods and compositions for treating depression and other disorders using optically pure (-) -bupropion |
| 08/22/2002 | US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 08/22/2002 | US20020115704 Treatment method |
| 08/22/2002 | US20020115683 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 08/22/2002 | US20020115676 Therapy for andropause using estrogen agonists / antagonists and testosterone |
| 08/22/2002 | US20020115654 New compounds, their preparation and use |
| 08/22/2002 | US20020115643 Such as enantiomorphs of 4-fluorostyryl-2,3,4,5,6-pentafluorobenzylsulfone; antiproliferative/anticancer agents |
| 08/22/2002 | US20020115622 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 08/22/2002 | US20020115205 Receptor protein for use in the treatment of cancer, infections, psoraisis, asthma, allergies, viral diseases, arteriosclerosis, gland, eye, autoimmune, nervous system and psychological disorders |
| 08/22/2002 | US20020114786 Pharmaceutical preparations comprising soybean isoflavone extracts and probiotic microogranisms |
| 08/22/2002 | US20020114776 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| 08/22/2002 | DE10107639A1 2-Alkoxyphenyl-substituierte Imidazotriazinone 2-alkoxy-phenyl-substituted imidazotriazinones |
| 08/22/2002 | CA2666611A1 Novel succinate salt of o-desmethyl-venlafaxine |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438113A1 2-alkoxyphenyl substituted imidazotriazinones |
| 08/21/2002 | EP1233015A1 Use of imidazole derivatives for the treatement of deseases involving the AT1 and AT2s receptors of angiotensine, some of these products, their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 08/21/2002 | EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 08/21/2002 | EP1232264A2 Human fgf-21 gene and gene expression products |
| 08/21/2002 | EP1232175A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 08/21/2002 | EP1232141A1 Ethers of o-desmethyl venlafaxine |
| 08/21/2002 | EP1231925A1 Method and composition for the treatment of adenoviral ocular infections |
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP0771192B1 Use of anti-vegf agents in the treatment of endometriosis |
| 08/21/2002 | EP0750501B1 Combined hormonal contraception pharmaceutical preparation |
| 08/21/2002 | CN1365363A thineopyranecarboxyamide derivatives |
| 08/21/2002 | CN1365285A Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvia area |
| 08/21/2002 | CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 08/21/2002 | CN1365282A Beta-carboline pharmaceutical compositions |
| 08/21/2002 | CN1364599A Nano blood tonifying medicine and its preparing method |
| 08/21/2002 | CN1364593A Medicine for treating impotence |
| 08/21/2002 | CN1364575A Nano motherwort menstruation regualting medicine and its preparing method |
| 08/21/2002 | CN1364562A Nano kidney tonifying medicine and its preparing method |
| 08/21/2002 | CN1364535A Nano eight ingredient Kunshun medicine and its preparing method |
| 08/21/2002 | CN1364521A Nano climacteria medicine and its preparing method |
| 08/21/2002 | CN1364514A Nano eight ingredient motherwort medicine and its preparing method |
| 08/21/2002 | CN1364503A Nano moleplant seed leukorrhea stopping preparation medicine and its preparing method |
| 08/21/2002 | CN1364489A Nano ten powerful tonics medicine and its preparing method |
| 08/21/2002 | CN1364484A Nano eleven ingredient Nengxiao medicine and its preparing method |
| 08/21/2002 | CN1364470A Nono five-seed Yanzong medicine and its preparing method |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/20/2002 | US6437158 Testosterone derivative |
| 08/20/2002 | US6437137 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6436997 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 08/20/2002 | US6436977 Dosing regimens for lasofoxifene |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436950 Effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects; sodium metabisulfite, ascorbic acid, or sodium ascorbate reducing agent |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436929 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436402 Process for making human papillomavirus virus-like particles with improved properties |
| 08/20/2002 | CA2240138C Quinazolin-4-one ampa antagonists |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002062838A1 Binding domain of siah (seven in absentia homolog) protein |
| 08/15/2002 | WO2002062800A1 Bicyclic nitrogenous fused-ring compound |
| 08/15/2002 | WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | WO2002062798A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062788A1 Sulfonamide compounds, their preparation and use |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002062391A2 Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea |
| 08/15/2002 | WO2002062355A2 Hydriodic acid and iodide salts for treatment of male impotence |
| 08/15/2002 | WO2002062343A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS |
| 08/15/2002 | WO2002062337A1 Thiazolidinediones |
| 08/15/2002 | WO2002062321A2 Method for producing a floating tablet containing an active principle |
| 08/15/2002 | WO2002062315A1 Rapid-onset medicament for the treatment of sexual dysfunction |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 08/15/2002 | WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | WO2002015938A3 Testosterone ester formulation for human use |
| 08/15/2002 | WO2001027135A9 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111369 Follicle stimulating hormone; contraceptives |
| 08/15/2002 | US20020111355 Antitumor agents; contraceptives |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020110568 Effective in eliciting the production of antibodies that recognize epitopes of native proteins |
| 08/15/2002 | CA2437630A1 Method for producing a floating tablet containing an active principle |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2435546A1 Rapid-onset medicament for the treatment of sexual dysfunction |
| 08/15/2002 | CA2435350A1 Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea |